Literature DB >> 15575057

Clinical practice. Newly diagnosed atrial fibrillation.

Richard L Page1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15575057     DOI： 10.1056/NEJMcp041956

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Controversies in the "pill in the pocket" approach to atrial fibrillation.

Authors:  Alessandro Riccardi; Roberto Lerza
Journal:  Intern Emerg Med       Date:  2008-02-16       Impact factor: 3.397

Review 2.  Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.

Authors:  David D McManus; Amir Y Shaikh; Fnu Abhishek; Ramachandran S Vasan
Journal:  Crit Pathw Cardiol       Date:  2011-03

Review 3.  Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety.

Authors:  Steven Deitelzweig
Journal:  Ochsner J       Date:  2013

4.  New treatment options for stroke prevention in atrial fibrillation.

Authors:  Benjamin Rhee; Richard L Page
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

5.  Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications.

Authors:  Miriam Shteinshnaider; Dorit Almoznino-Sarafian; Irena Alon; Irma Tzur; Sylvia Berman; Natan Cohen; Oleg Gorelik
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 6.  Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.

Authors:  David L Johnson; John D Day; Srijoy Mahapatra; T Jared Bunch
Journal:  J Atr Fibrillation       Date:  2012-02-02

Review 7.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

8.  Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation?

Authors:  James K Liao
Journal:  J Am Coll Cardiol       Date:  2010-02-02       Impact factor: 24.094

Review 9.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

10.  Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.

Authors:  Susan R Heckbert; Kerri L Wiggins; Nicole L Glazer; Sascha Dublin; Bruce M Psaty; Nicholas L Smith; W T Longstreth; Thomas Lumley
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.